A Multi-Institutional Comparison of Clinicopathological Characteristics and Oncologic Outcomes of Upper Tract Urothelial Carcinoma in China and the United States
- PMID: 27887951
- DOI: 10.1016/j.juro.2016.11.094
A Multi-Institutional Comparison of Clinicopathological Characteristics and Oncologic Outcomes of Upper Tract Urothelial Carcinoma in China and the United States
Abstract
Purpose: We evaluated differences in clinicopathological characteristics and oncologic outcomes between patients with upper tract urothelial carcinoma in mainland China and the United States.
Materials and methods: We retrospectively compiled clinicopathological and oncologic outcomes data on patients with upper tract urothelial carcinoma treated surgically at tertiary care medical facilities in the United States or China from 1998 to 2015. Baseline demographics, comorbidities and pathological features were evaluated. Oncologic end points, including intravesical recurrence and cancer specific survival, were obtained after excluding patients who received systemic chemotherapy. Multivariable Cox regression was performed to determine predictors of adverse oncologic outcomes for each country.
Results: A total of 775 patients with upper tract urothelial carcinoma were identified, including 451 in China and 324 in the United States. Median followup was 42 months. American patients were more frequently male (65% vs 44%) and smokers (79% vs 18%), and had a worse mean ASA® (American Society of Anesthesiologists®) score (2.7 vs 2.2) and prior bladder cancer (41% vs 4%, all p <0.001). Chinese patients more often had preoperative hydronephrosis (56% vs 40%), high grade pathology (98% vs 77%), muscle invasion (64% vs 38%) and nodal metastases (26% vs 6%, all p <0.001). American patients had worse overall survival on Kaplan-Meier analysis (p = 0.049). However, country of origin did not predict local relapse or cancer specific survival.
Conclusions: Patient and disease characteristics of upper tract urothelial carcinoma differed between the Chinese and American cohorts. Chinese patients appeared relatively healthier at presentation but more often exhibited adverse pathological features. While evaluation and management patterns may account for these variations, the pathological findings may reflect a differential underlying pathogenesis of disease. Additional study is warranted to further characterize these differences.
Keywords: China; United States; carcinoma; urinary tract; urothelium.
Copyright © 2017 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.J Urol. 2015 Dec;194(6):1561-6. doi: 10.1016/j.juro.2015.07.081. Epub 2015 Jul 17. J Urol. 2015. PMID: 26192256
-
Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract.Urol Oncol. 2014 Oct;32(7):981-8. doi: 10.1016/j.urolonc.2014.02.018. Epub 2014 Jul 9. Urol Oncol. 2014. PMID: 25022858
-
Oncologic Outcomes of Kidney Sparing Surgery versus Radical Nephroureterectomy for the Elective Treatment of Clinically Organ Confined Upper Tract Urothelial Carcinoma of the Distal Ureter.J Urol. 2016 May;195(5):1354-1361. doi: 10.1016/j.juro.2015.11.036. Epub 2015 Nov 21. J Urol. 2016. PMID: 26612196
-
Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review.World J Surg Oncol. 2016 Oct 20;14(1):270. doi: 10.1186/s12957-016-1021-3. World J Surg Oncol. 2016. PMID: 27765044 Free PMC article. Review.
-
Prognostic Value of Variant Histology in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Systematic Review and Meta-Analysis.J Urol. 2020 Jun;203(6):1075-1084. doi: 10.1097/JU.0000000000000523. Epub 2019 Sep 3. J Urol. 2020. PMID: 31479406
Cited by
-
Advanced Age May Not Be an Absolute Contraindication for Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma: A Single-Center Case Series and a Systematic Review with Meta-Analyses.J Clin Med. 2023 Nov 24;12(23):7273. doi: 10.3390/jcm12237273. J Clin Med. 2023. PMID: 38068325 Free PMC article. Review.
-
Validation of Hyponatremia as a Prognostic Predictor in Multiregional Upper Tract Urothelial Carcinoma.J Clin Med. 2020 Apr 23;9(4):1218. doi: 10.3390/jcm9041218. J Clin Med. 2020. PMID: 32340364 Free PMC article.
-
Precision in kidney-sparing surgery: Robot-assisted ureterectomy with novel Black Eye™ Ink.BJUI Compass. 2025 Feb 19;6(2):e502. doi: 10.1002/bco2.502. eCollection 2025 Feb. BJUI Compass. 2025. PMID: 39974347 Free PMC article.
-
Expression status of GATA3 and mismatch repair proteins in upper tract urothelial carcinoma.Front Med. 2019 Dec;13(6):730-740. doi: 10.1007/s11684-019-0687-7. Epub 2019 Apr 24. Front Med. 2019. PMID: 31020542
-
Upper Tract Urothelial Carcinoma (UTUC): Prevalence, Impact and Management Challenge.Cancer Manag Res. 2024 May 17;16:467-475. doi: 10.2147/CMAR.S445529. eCollection 2024. Cancer Manag Res. 2024. PMID: 38774494 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical